new raw materials workshop (b) put into operation. Production capacity reached a new level.

Yuankang Furui of Ningxia Pharmaceutical Co.,Ltd. which was one of holding company of Kangya was certified by GSP.

the company was awarded the title of the national torch plan high-tech enterprise.

new factory area began to construct.

the company was identified as national &local joint engineering laboratory, provincial new drug preparation technology innovation center and provincial enterprise technology center.

the product which was called indapamide SR had been rated as a national key new product by the Ministry of Science and Technology, Ministry of Environmental Protection, Ministry of Commerce, GAQSIQ and so on.

the company won the title of provincial high-tech enterprise.

the company had undertaked the NDRC high-tech industrialization demonstration project which was called ShengChang- indapamide SR industrial demonstration project. In the same year, the company’s branch of the R & D center was established.

the company had completed the upgrading of its products. New drugs which treated cardiovascular diseases, rheumatoid arthritis, eye diseases replaced old products.

the Kangya pharmaceutical factory and the northwest pharmaceutical Co., Ltd. merged into Kangya of Ningxia Pharmaceutical Co.,Ltd.

the Kangya pharmaceutical factory was founded.